Topotecan Completed Phase 2 Trials for Metastatic Cancers / Unspecified Adult Solid Tumor, Protocol Specific / Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003372Topotecan in Treating Patients With Recurrent Brain Tumors
NCT00002814Combination Chemotherapy for Patients With Brain Cancer
NCT00541138Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors